Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ACLS
ACLS logo

ACLS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Axcelis Technologies Inc (ACLS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
93.480
1 Day change
3.37%
52 Week Range
102.930
Analysis Updated At
2026/03/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Axcelis Technologies Inc (ACLS) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is experiencing a downward price trend, with no significant positive catalysts or trading signals to suggest immediate upside potential. Financial performance has weakened, and analysts have lowered price targets, reflecting concerns about near-term growth. Given the investor's scenario, it is better to hold off on buying until clearer signs of recovery or positive momentum emerge.

Technical Analysis

The technical indicators show mixed signals. While the MACD is positively expanding and moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the RSI is neutral at 74.015. The stock is trading near its resistance level (R1: 98.163) but has recently experienced a significant price drop (-2.48% in the regular market and -0.10% post-market). This suggests weak momentum and potential downside risk.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low Put-Call ratios indicate bullish sentiment in the options market. However, the overall trading volume is low, and implied volatility is moderate, suggesting limited immediate trading opportunities.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
7

Positive Catalysts

  • Gross margin increased YoY by 2.02% to 46.97%, indicating some operational efficiency improvements. Additionally, the options market sentiment appears mildly bullish.

Neutral/Negative Catalysts

  • Revenue, net income, and EPS all declined significantly YoY in Q4 2025, reflecting weak financial performance. Analysts have lowered price targets and expressed concerns about near-term growth, particularly due to China market risks and softer guidance. No significant news or trading activity from hedge funds, insiders, or Congress has been reported.

Financial Performance

In Q4 2025, revenue dropped by 5.58% YoY to $238.33M, net income declined by 31.35% YoY to $34.297M, and EPS fell by 28.57% YoY to $1.1. Despite these declines, gross margin increased by 2.02% YoY to 46.97%, indicating some operational improvements.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have recently lowered price targets (e.g., B. Riley to $91 from $94, BofA to $90 from $100) and expressed concerns about near-term growth and softer guidance. Ratings are Neutral or Underperform, with no strong buy recommendations. Analysts expect potential improvement in 2H26 but remain cautious about the current outlook.

Wall Street analysts forecast ACLS stock price to rise
3 Analyst Rating
Wall Street analysts forecast ACLS stock price to rise
1 Buy
1 Hold
1 Sell
Hold
Current: 90.430
sliders
Low
94
Averages
99.67
High
105
Current: 90.430
sliders
Low
94
Averages
99.67
High
105
B. Riley
B. Riley
Neutral
downgrade
$94 -> $91
AI Analysis
2026-02-18
Reason
B. Riley
B. Riley
Price Target
$94 -> $91
AI Analysis
2026-02-18
downgrade
Neutral
Reason
B. Riley lowered the firm's price target on Axcelis to $91 from $94 and keeps a Neutral rating on the shares. Axcelis delivered a strong Q4 beat driven by Services and Systems upside and still-elevated China exposure, but softer 1Q26 guidance and flattish CY26 revenue outlook, due to Mature Foundry digestion offsetting Memory gains, pressured shares, the analyst tells investors in a research note. While near-term gross margin compression appears mix-driven rather than structural, moderating expectations and a growing Memory contribution suggest improving 2H26 momentum despite guidance modestly below consensus, the firm says.
BofA
Duksan Jang
Underperform
downgrade
$100 -> $90
2026-02-18
Reason
BofA
Duksan Jang
Price Target
$100 -> $90
2026-02-18
downgrade
Underperform
Reason
BofA analyst Duksan Jang lowered the firm's price target on Axcelis to $90 from $100 and keeps an Underperform rating on the shares. The firm, which is waiting for clearer signs of recovery, lowered its calendar year 2026-28 sales estimates by 5%-8% and EPS estimates by 9%-16%.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ACLS
Unlock Now

People Also Watch